Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-10

Clinical Trial Update: Effect of Pretreatment of Lignocaine Versus Midazolam in Prevention of Etomidate Induced Myoclonus. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing pretreatment with lignocaine versus midazolam to prevent etomidate-induced myoclonus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etomidate (etomidate)
  • Lignocaine (lidocaine)
  • Midazolam (Midazolam)

Snippet

Sponsor: Rawalpindi Medical College | Conditions: Myoclonic Jerk | Phase 4 | Status: COMPLETED